Albireo Pharma, Inc. (ALBO): Price and Financial Metrics
ALBO Price/Volume Stats
| Current price | $44.15 | 52-week high | $45.23 |
| Prev. close | $44.25 | 52-week low | $16.02 |
| Day low | $43.99 | Volume | 1,241,200 |
| Day high | $44.90 | Avg. volume | 704,539 |
| 50-day MA | $37.97 | Dividend yield | N/A |
| 200-day MA | $25.15 | Market Cap | 913.95M |
ALBO Stock Price Chart Interactive Chart >
Albireo Pharma, Inc. (ALBO) Company Bio
Albireo Pharma, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and gastrointestinal (GI) disorders. The company is based in Boston, Massachusetts.
ALBO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 80.94% |
| 5-year | 132.12% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -7.21% |
| 2021 | -37.91% |
| 2020 | 47.56% |
| 2019 | 3.63% |
Continue Researching ALBO
Want to do more research on Albireo Pharma Inc's stock and its price? Try the links below:Albireo Pharma Inc (ALBO) Stock Price | Nasdaq
Albireo Pharma Inc (ALBO) Stock Quote, History and News - Yahoo Finance
Albireo Pharma Inc (ALBO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...